Format

Send to

Choose Destination
Clin Pharmacol Ther. 2014 Sep;96(3):307-9. doi: 10.1038/clpt.2014.101. Epub 2014 May 7.

Prerequisites to implementing a pharmacogenomics program in a large health-care system.

Author information

1
Division of Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
2
Division of Nephrology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
3
Department of Nursing Science Care, Indiana University School of Nursing, Indianapolis, Indiana, USA.
4
1] Division of Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA [2] Indiana Institute for Personalized Medicine, Indianapolis, Indiana, USA.
5
1] Division of Clinical Pharmacology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA [2] Health Information and Translational Sciences, Indianapolis, Indiana, USA.

Abstract

Pharmacogenomics (PGx) technology is advancing rapidly; however, clinical adoption is lagging. The Indiana Institute of Personalized Medicine (IIPM) places a strong focus on translating PGx research into clinical practice. We describe what have been found to be the key requirements that must be delivered in order to ensure a successful and enduring PGx implementation within a large health-care system.

PMID:
24807457
PMCID:
PMC4441093
DOI:
10.1038/clpt.2014.101
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center